| GBP millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | (0.0) | (0.0) | (0.0) | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 0.7 | 0.7 | 0.6 | 0.3 | 0.5 | 0.2 | −53.7% | |
| Selling & marketing | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | −100.0% | |
| Operating expenses | 0.9 | 0.9 | 0.9 | 0.4 | 0.6 | 0.4 | −22.7% | |
| Operating income | (0.9) | (0.9) | (0.9) | (0.4) | (0.6) | (0.4) | +22.7% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | 0.0 | (0.0) | (3.2) | (1.5) | (0.3) | 0.9 | +413.1% | |
| Pre-tax income | (0.9) | (0.9) | (4.0) | (1.9) | (0.8) | 0.4 | +151.0% | |
| Income tax | 0.0 | (0.0) | (0.3) | (0.0) | 0.0 | 0.0 | — | |
| Net income | (0.9) | (0.9) | (3.7) | (1.9) | (0.8) | 0.4 | +150.1% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (0.0) | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.01) | (0.01) | (0.03) | (0.01) | (0.01) | 0.00 | +142.2% | |
| EPS, diluted (per share) | (0.01) | (0.01) | (0.03) | (0.01) | (0.01) | 0.00 | +142.2% | |
| EBITDA | (0.9) | (0.9) | (4.0) | (0.3) | (0.6) | (0.4) | +38.9% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.9 | 0.0 | 0.0 | +0.0% | |
| Weighted average shares (shares) | 68,935,000 | 110,984,045 | 129,260,000 | 130,330,000 | 130,348,000 | 153,494,366 | +17.8% | |
| Weighted average diluted shares (shares) | 68,935,000 | 110,984,045 | 129,260,000 | 130,328,000 | 130,328,000 | 153,494,366 | +17.8% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
